4 min read
Sufferers with localized, hormone receptor-positive, HER2-low breast most cancers handled with trastuzumab deruxtecan (T-DXd, Enhertu) within the neoadjuvant setting had...
reports
4 min read
4 min read
4 min read
4 min read
Sufferers with localized, hormone receptor-positive, HER2-low breast most cancers handled with trastuzumab deruxtecan (T-DXd, Enhertu) within the neoadjuvant setting had...
3 min read
2 min read
2 min read
2 min read